| pubmed-article:20368573 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0024419 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0443315 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0092801 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:20368573 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:20368573 | pubmed:issue | 13 | lld:pubmed |
| pubmed-article:20368573 | pubmed:dateCreated | 2010-4-30 | lld:pubmed |
| pubmed-article:20368573 | pubmed:abstractText | To assess the efficacy of 2-chloro-2'-deoxyadenosine (2-CdA) given subcutaneously (SC) in combination with rituximab in the treatment of newly diagnosed/pretreated patients with Waldenström macroglobulinemia (WM) and to correlate the response to treatment with biologic findings (immunophenotypic and pharmacogenomic analysis). | lld:pubmed |
| pubmed-article:20368573 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20368573 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20368573 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20368573 | pubmed:month | May | lld:pubmed |
| pubmed-article:20368573 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:MartinelliGio... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:BillioAttoA | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:FabbriAlberto... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:RadiceDavideD | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:BertoliniFran... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:PruneriGianca... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:RigacciLuigiL | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:AndreolaGiova... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:MancusoPatriz... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:RabascioCrist... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:LaszloDaniele... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:FrigeriFerdin... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:CalabreseLili... | lld:pubmed |
| pubmed-article:20368573 | pubmed:author | pubmed-author:PintoAntonell... | lld:pubmed |
| pubmed-article:20368573 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20368573 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:20368573 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:20368573 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20368573 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20368573 | pubmed:pagination | 2233-8 | lld:pubmed |
| pubmed-article:20368573 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:meshHeading | pubmed-meshheading:20368573... | lld:pubmed |
| pubmed-article:20368573 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20368573 | pubmed:articleTitle | Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study. | lld:pubmed |
| pubmed-article:20368573 | pubmed:affiliation | Department of Hematology, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy. daniele.laszlo@ieo.it | lld:pubmed |
| pubmed-article:20368573 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20368573 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20368573 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20368573 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20368573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20368573 | lld:pubmed |
